NovaBay Pharmaceuticals Inc (NBY) — Cash Flow-to-Debt Ratio
NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of $-2.27 Million could theoretically repay 0% of its total liabilities ($31.86 Million) in one year. See NovaBay Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NovaBay Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for NovaBay Pharmaceuticals Inc across 21 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of NovaBay Pharmaceuticals Inc.
Annual Cash Flow-to-Debt Ratio for NovaBay Pharmaceuticals Inc (2005–2025)
Year-by-year debt coverage analysis for NovaBay Pharmaceuticals Inc. Check how high is NovaBay Pharmaceuticals Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-8.43 Million | $31.86 Million | ▲ +81.9% |
| 2024 | -1.46x | $-5.18 Million | $3.55 Million | ▼ -95.9% |
| 2023 | -0.74x | $-4.26 Million | $5.72 Million | ▲ +34.6% |
| 2022 | -1.14x | $-6.65 Million | $5.84 Million | ▼ -71.0% |
| 2021 | -0.67x | $-9.19 Million | $13.81 Million | ▲ +58.8% |
| 2020 | -1.62x | $-4.72 Million | $2.92 Million | ▼ -108.9% |
| 2019 | -0.77x | $-7.93 Million | $10.25 Million | ▲ +38.8% |
| 2018 | -1.26x | $-5.57 Million | $4.41 Million | ▼ -50.8% |
| 2017 | -0.84x | $-6.27 Million | $7.49 Million | ▲ +42.8% |
| 2016 | -1.47x | $-12.13 Million | $8.28 Million | ▲ +19.6% |
| 2015 | -1.82x | $-18.56 Million | $10.18 Million | ▲ +31.1% |
| 2014 | -2.65x | $-15.05 Million | $5.69 Million | ▼ -45.6% |
| 2013 | -1.82x | $-12.97 Million | $7.13 Million | ▼ -44.4% |
| 2012 | -1.26x | $-6.53 Million | $5.19 Million | ▼ -165.2% |
| 2011 | -0.47x | $-3.14 Million | $6.62 Million | ▼ -217.6% |
| 2010 | 0.40x | $2.03 Million | $5.03 Million | ▲ +202.3% |
| 2009 | -0.39x | $-1.65 Million | $4.18 Million | ▲ +73.7% |
| 2008 | -1.50x | $-9.94 Million | $6.62 Million | ▼ -129.8% |
| 2007 | -0.65x | $-6.27 Million | $9.60 Million | ▼ -238.4% |
| 2006 | 0.47x | $4.74 Million | $10.05 Million | ▲ +104.5% |
| 2005 | -10.42x | $-3.23 Million | $310.00K | — |